Analytical Data
-
基因名
SYNM
- Application
-
别名
Desmuslin
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O15061
-
表达区间
1241-1565 aa
-
氨基酸序列
SAAGKVGDYFATEESVGTQTSVRQLQLGPKEGFSGQIQFTAPLSDKVELGVIGDSVHMEGLPGSSTSIRHISIGPQRHQTTQQIVYHGLVPQLGESGDSESTVHGEGSADVHQATHSHTSGRQTVMTEKSTFQSVVSESPQEDSAEDTSGAEMTSGVSRSFRHIRLGPTETETSEHIAIRGPVSRTFVLAGSADSPELGKLADSSRTLRHIAPGPKETSFTFQMDVSNVEAIRSRTQEAGALGVSDRGSWRDADSRNDQAVGVSFKASAGEGDQAHREQGKEQAMFDKKVQLQRMVDQRSVISDEKKVALLYLDNEEEENDGHWF
-
分子量
42kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SYNM (Synaptopodin-2) is a protein that has gained significant attention in recent years due to its role in synaptic function and plasticity. Originally identified in neurons, SYNM is believed to play a crucial role in the development and maintenance of dendritic spines, which are essential for synaptic transmission and cognitive processes such as learning and memory. Recent studies have suggested that SYNM may be involved in various neurological disorders, including schizophrenia, autism spectrum disorders, and neurodegeneration, highlighting its potential as a therapeutic target. Researchers are increasingly focused on understanding the molecular mechanisms underlying SYNM's function, such as its interactions with other proteins and its regulatory pathways. Additionally, advances in protein engineering and expression systems have enabled the production of recombinant SYNM, facilitating in-depth studies of its structure and function. The exploration of SYNM recombinant proteins will not only enhance our understanding of synaptic dynamics but also provide insights into developing novel treatments for affective disorders and neurodevelopmental conditions.
